다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
한국임상약학회지 = Korean journal of clinical pharmacy, v.33 no.2, 2023년, pp.86 - 96
구현지 (중앙대학교 약학대학) , 권준영 (중앙대학교 제약산업학과) , 최재혁 (중앙대학교 제약산업학과) , 유승훈 (중앙대학교 대학원 글로벌혁신신약학과) , 박세원 (중앙대학교 대학원 글로벌혁신신약학과) , 정경혜 (중앙대학교 약학대학) , 정선영 (중앙대학교 약학대학)
AI-Helper
Background: Using KIDS-KAERS database (KIDS-KD) from 2016 to 2020, the aim is to investigate signals of adverse events of alpha-adrenoceptor antagonists and to present adverse events that are not included in the precautions for use when marketing approval. Methods: This study was conducted by dispro...
Miernik A, Gratzke C. Current treatment for benign prostatic hyperplasia. Dtsch Arztebl Int 2020;117(49):843.？
Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: Aua guideline part i-initial work-up and medical management. J Urol 2021;206(4):806-17.？
Kim DK, Park JJ, Yang WJ, Doo SW, Kim JH, Song YS. Changes in diagnosis rate and treatment trends of benign prostatic hyperplasia in Korea: A nationwide population-based cohort study. Prostate International 2021;9(4):215-20.？
Del Giudice F, Oh JK, Basran S, et al. Recent trends in the diagnostic and surgical management of benign prostatic hyperplasia in the us from 2004 to 2017: Annual changes in the selection of treatment options and medical costs. Applied Sciences 2022;12(17):8697.？
Kumar V, Dewan S. Alpha adrenergic blockers in the treatment of benign hyperplasia of the prostate. Int Urol Nephrol 2000;32(1):67-71.？
Yu Z-W, Wang R-H, Zhang C-C, Gao J-G. The efficacy and safety of alpha-adrenergic blockers for medical expulsion therapy in patients with ureteral calculi: A meta-analysis of placebo-controlled trials. Medicine (Baltimore) 2021;100(37):e27272.？
Li H, Xu TY, Li Y, et al. Role of α1-blockers in the current management of hypertension. J Clin Hypertens (Greenwich) 2022;24(9):1180-6.？
Duan Y, Grady JJ, Albertsen PC, Helen Wu Z. Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia. Pharmacoepidemiol Drug Saf 2018;27(3):340-8.？
Latvala L, Tiihonen M, Murtola TJ, Hartikainen S, Tolppanen AM. Use of α1-adrenoceptor antagonists tamsulosin and alfuzosin and the risk of alzheimer's disease. Pharmacoepidemiol Drug Saf 2022;31(10):1110-20.？
Inoue A, Sawada Y, Ohmori S, et al. Maculopapular type drug eruption caused by silodosin. Allergol Int 2016;65(2):219-20.？
Klimi E. A probable case of mucosal fixed drug eruption following treatment with silodosin. Sultan Qaboos Univ Med J 2018;18(3):e402.？
Yoshimura K, Kadoyama K, Sakaeda T, Sugino Y, Ogawa O, Okuno Y. A survey of the faers database concerning the adverse event profiles of α1-adrenoreceptor blockers for lower urinary tract symptoms. Int J Med Sci 2013;10(7):864.？
Ohyama K, Hori Y, Sugiura M. Evaluation of syncope association with α1-adrenoceptor blockers in males using the FAERS database: Impact of concomitant hypertension Pharmazie 2019;74(12):755-9.？
Ohyama K, Furumoto M, Sugiura M. Onset time profiles for syncope associated with α1-adrenoceptor blockers in males: Analysis of a spontaneous adverse drug event database. Pharmacology & Pharmacy 2018;9(12):515-26.？
Jang M-G, Gu H-J, Kim J, Shin K-H. Signal detection for adverse event of varenicline in Korea adverse event reporting system. Korean J Clin Pharm 2022;32(1):1-7.？
European Medicine Agency. Inclusion/exclusion criteria for the "Important Medical Events" list. Available from https://www.ema.europa.eu/en/documents/other/inclusion-exclusion-criteria-important-medical-events-list-meddra_en.pdf. Accessed May 30, 2023.？
van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions Pharmacoepidemiol Drug Saf 2002;11(1):3-10.？
Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001;10(6):483-6.？
Shin JY, Jung SY, Ahn SH, et al. New initiatives for pharmacovigilance in south korea: Introducing the korea institute of drug safety and risk management (kids). Pharmacoepidemiol Drug Saf 2014;23(11):1115-22.？
Medication Information Bulletin Board. Ministry of Food and Drug Safety, Available from https://nedrug.mfds.go.kr/searchDrug. Accessed May 30, 2023.？
Kaplan SA, McCammon K, Fincher R, Fakhoury A, He W. Safety and tolerability of solifenacin add-on therapy to α-blocker treated men with residual urgency and frequency. J Urol 2013;189(1):S129-34.？
Nishizawa O, Yamaguchi O, Takeda M, Yokoyama O, Group TS. Randomized controlled trial to treat benign prostatic hyperplasia with overactive bladder using an alpha-blocker combined with anticholinergics. Low Urin Tract Symptoms 2011;3(1):29-35.？
McKiernan JM, Lowe FC. Side effects of terazosin in the treatment of symptomatic benign prostatic hyperplasia. South Med J 1997;90(5):509-13.？
Thomsen RW, Christiansen CF, Heide-Jorgensen U, et al. Association of α1-blocker receipt with 30-day mortality and risk of intensive care unit admission among adults hospitalized with influenza or pneumonia in Denmark. JAMA Netw Open 2021;4(2):e2037053.？
Sirak TE, Jelic S, Le Jemtel TH. Therapeutic update: Non-selective beta-and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 2004;44(3):497-502.？
Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis 2014;1(1):871-88.？
Raherison C, Girodet P. Epidemiology of COPD. Eur Respir Rev 2009;18(114):213-21.？
Welk B, McArthur E, Fraser L-A, et al. The risk of fall and fracture with the initiation of a prostate-selective α antagonist: A population based cohort study. BMJ 2015;351:h5398.？
Seo G-H, Lee Y-K, Ha Y-C. Risk of hip fractures in men with alpha-blockers: A nationwide study base on claim registry. J Bone Metab 2015;22(1):29-32.？
Bonnell LN, SooHoo JR, Seibold LK, et al. One-day postoperative intraocular pressure spikes after phacoemulsification cataract surgery in patients taking tamsulosin. J Cataract Refract Surg 2016;42(12):1753-8.？
Zheng W, Dryja TP, Wei Z, et al. Systemic medication associations with presumed advanced or uncontrolled primary open-angle glaucoma. Ophthalmology 2018;125(7):984-93.？
Lee JW, Lee HJ. Reversible visual loss caused by combination therapy of alfuzosin and finasteride in a patient with uveitic glaucoma. Cutan Ocul Toxicol 2013;32(2):182-4.？
Ghuman A, Kasteel N, Karimuddin AA, Brown CJ, Raval MJ, Phang PT. Urinary retention in early urinary catheter removal after colorectal surgery. Am J Surg 2018;215(5):949-52.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.